+935.6%
MPWR vs MRNA
+521.0%
+414.6%
-51.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.5% | +0.7% | -2.2% | -1.5% |
| 7D | -2.3% | -8.2% | +6.0% | -1.6% |
| 30D | -15.4% | +125.6% | -141.0% | -27.9% |
| 3M | -19.4% | +197.1% | -216.4% | -35.2% |
| 6M | +12.7% | +148.5% | -135.8% | -7.0% |
| YTD | +31.3% | +363.3% | -332.0% | -3.2% |
| 1Y | +39.7% | +462.0% | -422.3% | -1.2% |
| 3Y | +142.2% | +26.9% | +115.3% | +105.5% |
| 5Y | +149.0% | -69.6% | +218.6% | +130.1% |
| All | +935.6% | +521.0% | +414.6% | +721.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling